Back

prof. dr. E. (Eva) van Rooij

Full Professor

  • Onderzoek Molecular Cardiology

  1. Contact
  2. Research Programs
  3. Research Output

Contact

E

Research Programs

Research Output (27)

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (vol 10, 9819, 2020):The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Eijgenraam Tim R., Boukens Bastiaan J., Boogerd Cornelis J., Schouten E. Marloes, van de Kolk Cees W.A., Stege Nienke M., te Rijdt Wouter P., Hoorntje Edgar T., van der Zwaag Paul A., van Rooij Eva, van Tintelen J. Peter, van den Berg Maarten P., van der Meer Peter, van der Velden Jolanda, Silljé Herman H.W., de Boer Rudolf A. 2 okt 2020, In: Scientific Reports. 10

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy

Eijgenraam Tim R, Boukens Bastiaan J, Boogerd Cornelis J, Schouten E Marloes, van de Kolk Cees W A, Stege Nienke M, Te Rijdt Wouter P, Hoorntje Edgar T, van der Zwaag Paul A, van Rooij Eva, van Tintelen Peter, van den Berg Maarten P, van der Meer Peter, van der Velden Jolanda, Silljé Herman H W, de Boer Rudolf A 17 jun 2020, In: Scientific Reports. 10 13 p.

Turning basic science discoveries into successful commercial opportunities

Van Rooij Eva 1 okt 2019, In: Cardiovascular Research. 115 , p. E127-E129

CRISPR Craze to Transform Cardiac Biology

van Kampen Sebastiaan Johannes, van Rooij Eva 1 sep 2019, In: Trends in molecular medicine. 25 , p. 791-802 12 p.

Sex Differences in Science:Do We Have a Problem?

van Rooij Eva, Bishopric Nanette H. 1 aug 2019, In: JACC: Basic to Translational Science. 4 , p. 478-479 2 p.

Micrornas as companion biomarkers for the diagnosis and prognosis of acute coronary syndromes

Condorelli Gianluigi, Van Rooij Eva 19 jul 2019, In: Circulation research. 125 , p. 341-342 2 p.

Keeping the Heart Fitm2 during Chemotherapy

Eding Joep E.C., van Rooij Eva 2 jan 2019, In: Molecular Therapy. 27 , p. 10-12 3 p.

Profiling proliferative cells and their progeny in damaged murine hearts

Kretzschmar Kai, Post Yorick, Bannier-Hélaouët Marie, Mattiotti Andrea, Drost Jarno, Basak Onur, Li Vivian S.W., van den Born Maaike, Gunst Quinn D., Versteeg Danielle, Kooijman Lieneke, van der Elst Stefan, van Es Johan H., van Rooij Eva, van den Hoff Maurice J.B., Clevers Hans 26 dec 2018, In: Proceedings of the National Academy of Sciences of the United States of America. 115 , p. E12245-E12254

Controlled Release of RNAi Molecules by Tunable Supramolecular Hydrogel Carriers

Bakker Maarten H., van Rooij Eva, Dankers Patricia Y.W. 16 nov 2018, In: Chemistry - An Asian Journal. 13 , p. 3501-3508 8 p.

Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation

Gladka Monika M., Molenaar Bas, De Ruiter Hesther, Van Der Elst Stefan, Tsui Hoyee, Versteeg Danielle, Lacraz Grègory P.A., Huibers Manon M.H., Van Oudenaarden Alexander, Van Rooij Eva 10 jul 2018, In: Circulation. 138 , p. 166-180 15 p.

All Research Output (27)